Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation
Sascha Dietrich(European Molecular Biology Organization), Carmen Martı́nez(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Silvia Montoto(Queen Mary University of London), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Mohamad Mohty(Sorbonne Université), Luca Castagna(Humanitas University), Didier Blaise(Institut Paoli-Calmettes), P. Chevallier(Centre Hospitalier Universitaire de Nice), Stephen Robinson(Intel (United States)), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Johanna Tischer(LMU Klinikum), Paolo Corradini(Gruppo di Ricerca Geriatrica), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Peter Dreger(Heidelberg University), Andrea Bacigalupo(Università Cattolica del Sacro Cuore), Andreas Hausmann(München Klinik Schwabing), Ariane Boumendil(Inserm), H Finel(European Society for Blood and Marrow Transplantation)
Cited by 44
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k